Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Harmony CBD, formerly known as Palmetto Harmony, is a private U.S. hemp-derived CBD company focused on consumer wellness products rather than prescription drug development. The company was founded by Janel Ralph after using cannabidiol in an effort to help her daughter Harmony, who suffers from a severe seizure disorder associated with lissencephaly. Harmony CBD describes itself as a vertically integrated operation that grows hemp, extracts cannabinoids, bottles products, and distributes them from Conway, South Carolina. Its commercial portfolio includes full-spectrum CBD tinctures, capsules, topicals, transdermal patches, suppositories, vape products, and related wellness offerings. The business appears to operate in the nutraceutical/cannabinoid wellness segment of healthcare, with an emphasis on USDA-certified organic hemp, third-party testing, and direct-to-consumer sales.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Harmony CBD.